Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients.
Lithium carbonate (LiCO3) was used to treat 10 brain-injured patients with severe, unremitting, aggressive, combative, or self destructive behavior or severe affective instability. Five patients had a dramatic response that resulted in significant improvement in their participation in a rehabilitative program. One other patient had a moderate response. A seventh patient improved dramatically, but regressed after 7 wk. Three other patients had neurotoxic side effects that precluded continued use of the medication. Two of them were simultaneously taking neuroleptic agents. These case reports provide further evidence that LiCO3 can be a useful medication in the treatment of aggressive behavior and affective instability after brain injury, but that it has significant potential for neurotoxicity in this population, particularly when used in conjunction with neuroleptic agents.
Glenn
M B
MB
New England Medical Center Hospitals, Boston, Massachusetts.
Wroblewski
B
B
Parziale
J
J
Levine
L
L
Whyte
J
J
Rosenthal
M
M
D000328:Adult; D000368:Aged; D000374:Aggression / Q000187:drug effects*; D001930:Brain Injuries / Q000150:complications* / Q000534:rehabilitation; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D012652:Self Mutilation / Q000188:drug therapy
D016651:Lithium Carbonate; D008094:Lithium